HSDL2 overexpression promotes rectal cancer progression by regulating cancer cell cycle and promoting cell proliferation.
10.12122/j.issn.1673-4254.2023.04.06
- Author:
Yang CHENG
1
;
Xuxu HE
2
;
Lian WANG
2
;
Yibo XU
2
;
Mengdi SHEN
2
;
Wenjing ZHANG
2
;
Yongsheng XIA
2
;
Jie ZHANG
2
;
Min ZHANG
2
;
Yijun WANG
2
;
Jianguo HU
3
;
Jun HU
1
Author Information
1. Department of Blood Transfusion, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
2. Bengbu Medical College, Bengbu 233000, China.
3. Clinical Laboratory, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
- Publication Type:Journal Article
- Keywords:
HSDL2;
biomarkers;
cell cycle;
cell proliferation;
rectal cancer
- MeSH:
Humans;
CA-19-9 Antigen;
Ki-67 Antigen/metabolism*;
Prospective Studies;
Cell Line, Tumor;
Cell Proliferation/genetics*;
Rectal Neoplasms/genetics*;
Cell Cycle;
Gene Expression Regulation, Neoplastic;
Hydroxysteroid Dehydrogenases/metabolism*
- From:
Journal of Southern Medical University
2023;43(4):544-551
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the expression of hydroxysteroid dehydrogenase like 2 (HSDL2) in rectal cancer tissues and the effect of changes in HSDL2 expression level on proliferation of rectal cancer cells.
METHODS:Clinical data and tissue samples of 90 patients with rectal cancer admitted to our hospital from January 2020 to June 2022 were collected from the prospective clinical database and biological specimen database. The expression level of HSDL2 in rectal cancer and adjacent tissues was detected by immunohistochemistry, and based on the median level of HSDL2 expression, the patients were divided into high expression group (n=45) and low expression group (n=45) for analysis the correlation between HSDL2 expression level and the clinicopathological parameters. GO and KEGG enrichment analyses were performed to explore the role of HSDL2 in rectal cancer progression. The effects of changes in HSDL2 expression levels on rectal cancer cell proliferation, cell cycle and protein expressions were investigated in SW480 cells with lentivirus-mediated HSDL2 silencing or HSDL2 overexpression using CCK-8 assay, flow cytometry and Western blotting.
RESULTS:The expressions of HSDL2 and Ki67 were significantly higher in rectal cancer tissues than in the adjacent tissues (P < 0.05). Spearman correlation analysis showed that the expression of HSDL2 protein was positively correlated with Ki67, CEA and CA19-9 expressions (P < 0.01). The rectal cancer patients with high HSDL2 expressions had significantly higher likelihood of having CEA ≥5 μg/L, CA19-9 ≥37 kU/L, T3-4 stage, and N2-3 stage than those with a low HSDL2 expression (P < 0.05). GO and KEGG analysis showed that HSDL2 was mainly enriched in DNA replication and cell cycle. In SW480 cells, HSDL2 overexpression significantly promoted cell proliferation, increased cell percentage in S phase, and enhanced the expression levels of CDK6 and cyclinD1 (P < 0.05), and HSDL2 silencing produced the opposite effects (P < 0.05).
CONCLUSION:The high expression of HSDL2 in rectal cancer participates in malignant progression of the tumor by promoting the proliferation and cell cycle progress of the cancer cells.
